Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
AI-Powered Precision For Colony Counting
27 Mar 2025
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
03 Apr 2025 -
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
07 Apr 2025 -
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
11 Apr 2025 -
IBQC 2025
14 Apr 2025 -
IFU Technical Workshop 2025
15 Apr 2025 -
Validation of Water Systems for Microbial Control
23 Apr 2025 -
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
29 Apr 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025